BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27861263)

  • 1. Mechanisms of graft rejection after lung transplantation.
    Hsiao HM; Scozzi D; Gauthier JM; Kreisel D
    Curr Opin Organ Transplant; 2017 Feb; 22(1):29-35. PubMed ID: 27861263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive features of innate immune cells and their relevance to graft rejection.
    Wang G; Kong G; Li XC
    Curr Opin Organ Transplant; 2019 Dec; 24(6):664-669. PubMed ID: 31577598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immunity in ischemia-reperfusion injury and graft rejection.
    Nakamura K; Kageyama S; Kupiec-Weglinski JW
    Curr Opin Organ Transplant; 2019 Dec; 24(6):687-693. PubMed ID: 31592839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The innate immune response to allotransplants: mechanisms and therapeutic potentials.
    Ochando J; Ordikhani F; Boros P; Jordan S
    Cell Mol Immunol; 2019 Apr; 16(4):350-356. PubMed ID: 30804476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.
    Hu H; Zhu X; Joshi S; Lu L; Xia CQ; Patel JM
    PLoS One; 2015; 10(5):e0124705. PubMed ID: 25933390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CD4+ and CD8+ T cells in the rejection of heart or islet xenografts in recipients with xenotolerance in the innate immune compartment.
    Devos T; Yan Y; Segers C; Rutgeerts O; Laureys J; Gysemans C; Mathieu C; Waer M
    Transplant Proc; 2005; 37(1):516-7. PubMed ID: 15808695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview on non-T cell pathways in transplant rejection and tolerance.
    Liu W; Li XC
    Curr Opin Organ Transplant; 2010 Aug; 15(4):422-6. PubMed ID: 20531193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immunity in heart transplantation.
    Millington TM; Madsen JC
    Curr Opin Organ Transplant; 2009 Oct; 14(5):571-6. PubMed ID: 19542889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The innate natural killer cells in transplant rejection and tolerance induction.
    Kroemer A; Edtinger K; Li XC
    Curr Opin Organ Transplant; 2008 Aug; 13(4):339-43. PubMed ID: 18685327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.
    Todd JL; Wang X; Sugimoto S; Kennedy VE; Zhang HL; Pavlisko EN; Kelly FL; Huang H; Kreisel D; Palmer SM; Gelman AE
    Am J Respir Crit Care Med; 2014 Mar; 189(5):556-66. PubMed ID: 24471427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immunity and organ transplantation: focus on lung transplantation.
    Kreisel D; Goldstein DR
    Transpl Int; 2013 Jan; 26(1):2-10. PubMed ID: 22909350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of innate and adaptive immunity on rejection and tolerance.
    Kim IK; Bedi DS; Denecke C; Ge X; Tullius SG
    Transplantation; 2008 Oct; 86(7):889-94. PubMed ID: 18852649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulatory blockade-mediated lung allograft acceptance is abrogated by overexpression of Bcl-2 in the recipient.
    Okazaki M; Sugimoto S; Lai J; Kornfeld CG; Hotchkiss RS; Richardson SB; Li W; Kreisel FH; Huang HJ; Patterson GA; Krupnick AS; Gelman AE; Kreisel D
    Transplant Proc; 2009; 41(1):385-7. PubMed ID: 19249562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The number of regulatory T cells in transbronchial lung allograft biopsies is related to FoxP3 mRNA levels in bronchoalveolar lavage fluid and to the degree of acute cellular rejection.
    Krustrup D; Madsen CB; Iversen M; Engelholm L; Ryder LP; Andersen CB
    Transpl Immunol; 2013 Dec; 29(1-4):71-5. PubMed ID: 23969200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular mechanisms underlying acute graft rejection: time for reassessment.
    Alegre ML; Florquin S; Goldman M
    Curr Opin Immunol; 2007 Oct; 19(5):563-8. PubMed ID: 17720467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immunity in transplant tolerance and rejection.
    Murphy SP; Porrett PM; Turka LA
    Immunol Rev; 2011 May; 241(1):39-48. PubMed ID: 21488888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome.
    Bhorade SM; Chen H; Molinero L; Liao C; Garrity ER; Vigneswaran WT; Shilling R; Sperling A; Chong A; Alegre ML
    Transplantation; 2010 Sep; 90(5):540-6. PubMed ID: 20628341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immunity in lung transplantation.
    Shepherd HM; Gauthier JM; Li W; Krupnick AS; Gelman AE; Kreisel D
    J Heart Lung Transplant; 2021 Jul; 40(7):562-568. PubMed ID: 34020867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors, innate immunity and lung transplantation.
    Snyder LD; Palmer SM
    Front Biosci (Elite Ed); 2009 Jun; 1(2):600-4. PubMed ID: 19482676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.